JPRN-UMIN000042482招募中未知
Effect of Semaglutide 0.25mg on glycemic controls in type2 diabetes patients compared with dulaglutide 0.75mg. - Effect of Semaglutide 0.25mg on glycemic controls in type2 diabetes patients compared with dulaglutide 0.75mg.
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Pationts received insulin 2) Patients with severe liver dysfunction 3) Patients with severe renal dysfunction(eGFR<30ml/min/1.73) 4) Patients with fasting serum CPR <0.5 or postprandial serum CPR <1.0 5) Patients taking steroid 6) Patients with malignant tumor currently undergoing treatment 7) Pregnant or lactating woman 8) Other patients who are judged to be unsuitable as subjects by the judgment of a doctor
研究者
相似试验
招募中
不适用
Effect of oral semaglutide on glucose variability and oxidative stress in type 2 diabetes patientstype 2 diabetesJPRN-jRCT1031210620Ohara Makoto58
已完成
不适用
Effect of oral semaglutide on glucose variability and oxidative stress in type 2 diabetes patientsType 2 diabetes mellitusJPRN-UMIN000046938Showa University School of Medicine, Division of Diabetes and Endocrinology, Department of Internal Medicine60
已完成
不适用
Effect of semaglutide on glucose variability and oxidative stress in type 2 diabetes patientsJPRN-UMIN000042670Showa University School of Medicine, Division of Diabetes and Endocrinology, Department of Internal Medicine42
进行中（未招募）
3 期
A research study to look at how semaglutide compared to placebo affects diabetic eye disease in people with type 2 diabetes (FOCUS)CTRI/2019/06/019817ovo Nordisk AS
进行中（未招募）
1 期
Research study to look at how well semaglutide works in people living with heart failure, obesity and type 2 diabetesHeart failure with preserved ejection fractionDiabetes Mellitus, type 2MedDRA version: 20.1Level: LLTClassification code 10076396Term: Heart failure with preserved ejection fractionSystem Organ Class: 100000004849EUCTR2020-004170-22-ATovo Nordisk A/S610